Factor I activators comprise a class of chemicals that modulate the activity of the protein known as Factor I, which is a serine protease primarily involved in the downregulation of the complement system. The complement system is a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells, promote inflammation, and attack the pathogen's cell membrane. Factor I specifically cleaves and inactivates C3b and C4b, which are bound to the cell surface, thus preventing the formation of the C3 and C5 convertases and the propagation of the complement cascade.
Direct activators of Factor I can bind to the protein, inducing a conformational change that either exposes the active site more effectively or enhances its enzymatic activity to cleave C3b and C4b. These activators may mimic the structure of the natural substrates or cofactors, stabilizing the enzyme-substrate complex and increasing the efficiency of the catalytic process. By enhancing the proteolytic function of Factor I, these chemicals can increase the rate at which it regulates the complement system by inactivating key components that propagate the immune response. Indirect activators might affect the expression of the Factor I gene, leading to an increase in the synthesis of the protein, or they could impact the protein's stability and half-life. Additionally, these activators may work by promoting the interaction between Factor I and its cofactors, such as complement factor H (CFH) or complement receptor 1 (CR1), which are necessary for its activity on C3b and C4b. Other indirect mechanisms could involve modulating the cellular or extracellular environment to favor the activation and function of Factor I.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can influence cell signaling and potentially affect the expression of Factor I. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels which can activate calcium-dependent signaling pathways, potentially influencing Factor I activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
This compound can increase cAMP levels, potentially enhancing cAMP-dependent pathways that could indirectly influence Factor I activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, via beta-adrenergic receptors, can increase cAMP levels, potentially influencing the cAMP-dependent pathways that could affect Factor I. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a PDE4 inhibitor that can increase intracellular cAMP levels, potentially enhancing cAMP-dependent pathways that could affect Factor I. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor that increases intracellular cAMP levels, potentially influencing cAMP-dependent pathways that could affect Factor I. | ||||||
Salmeterol | 89365-50-4 | sc-224277 sc-224277A | 10 mg 50 mg | $186.00 $562.00 | 1 | |
Salmeterol is a long-acting beta2-adrenergic receptor agonist that can increase cAMP levels, potentially influencing cAMP-dependent pathways that could affect Factor I. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels, potentially enhancing cAMP-dependent pathways that could indirectly influence Factor I. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Albuterol is a beta2-adrenergic receptor agonist that can increase cAMP levels, potentially influencing cAMP-dependent pathways that could affect Factor I. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through D1-like receptors, can increase cAMP levels, potentially enhancing cAMP-dependent pathways that could indirectly influence Factor I. | ||||||